Wave life sciences reports fourth quarter and full year 2021 financial results and provides business update

Clinical data from multiple novel, pn-modified stereopure oligonucleotides for als/ftd, dmd, and hd expected in 2022
WVE Ratings Summary
WVE Quant Ranking